Portable Ultrasound to Predict Heart Failure Readmission Risk

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-30

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to use a handheld ultrasound to assess patients with congestive heart failure (CHF) to see if the ultrasound can help predict readmission to the hospital. The study will include patients who are admitted to the hospital for CHF. Participants will have two ultrasounds at hospital discharge and at a follow up visit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study

NCT02996032

Heart Failure

COMPLETED

Impact of Immediate Point-of-Care Ultrasound on Patients With Cardiopulmonary Symptoms in the Emergency Department

NCT02861508

Chest Pain Dyspnea Syncope +1 more

COMPLETED NA

Bedside Ultrasound Identifies Congestive Heart Failure

NCT00833144

Heart Failure Dyspnea

COMPLETED

Pre-Hospital Lung Ultrasound Impact on Diagnosis

NCT05461547

Acute Heart Failure

SUSPENDED NA

Boston Medical Center Ultrasound Decongestion Study in Heart Failure

NCT07096726

Congestive Heart Failure Volume Overload

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this research is to see if a portable ultrasound can help predict readmission to the hospital for patients who are admitted to the hospital for CHF. The study will enroll patients who take part in Mobile Integrated Healthcare as part of their routine care. Participants will have two ultrasounds. The first ultrasound will be at hospital discharge.

Between seven to ten days after hospital discharge participants will be visited at their home in follow-up as the usual standard of care for Mobile Integrated Healthcare. At this visit participants will have a second ultrasound. Participants will be followed for one year for hospital readmission.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Patient Readmission

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultrasound

Ultrasound at hospital discharge and at follow up in 7-10 days

Group Type EXPERIMENTAL

Ultrasound

Intervention Type DIAGNOSTIC_TEST

Ultrasound at hospital discharge and at follow up at 7-10 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Ultrasound at hospital discharge and at follow up at 7-10 days

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary admission diagnosis is listed as congestive heart failure, with an acute component of decompensation.
* Age greater than 18 years.
* Principal residence within the geographic reach of our MIH program.